PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Regeneron Pharmaceuticals stock at 5.44%, Amgen at 5.36%, Vertex Pharmaceuticals at 5.23%, CareDx at 5.19%, and Royalty Pharma at 4.76%.

Total Holdings

Top 10 Percentage

46.07%

Asset Class

Equity

ETF Category

Health

Assets

401.81M

PE Ratio

23.15

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	REGN	Regeneron Pharmaceuticals, Inc.	5.44%	25,865
2	AMGN	Amgen Inc.	5.36%	48,871
3	VRTX	Vertex Pharmaceuticals Incorporated	5.23%	37,732
4	CDNA	CareDx, Inc.	5.19%	415,995
5	RPRX	Royalty Pharma plc	4.76%	305,038
6	BIIB	Biogen Inc.	4.69%	85,075
7	GILD	Gilead Sciences, Inc.	4.40%	122,866
8	UTHR	United Therapeutics Corporation	3.83%	28,357
9	PTGX	Protagonist Therapeutics, Inc.	3.59%	89,591
10	TECH	Bio-Techne Corporation	3.56%	186,851
11	HALO	Halozyme Therapeutics, Inc.	3.50%	130,441
12	RGEN	Repligen Corporation	3.40%	77,791
13	ALNY	Alnylam Pharmaceuticals, Inc.	3.28%	55,601
14	ACAD	ACADIA Pharmaceuticals Inc.	3.27%	421,512
15	BMRN	BioMarin Pharmaceutical Inc.	3.14%	169,509
16	ILMN	Illumina, Inc.	3.14%	61,695
17	VCEL	Vericel Corporation	3.02%	256,266
18	BCRX	BioCryst Pharmaceuticals, Inc.	2.96%	1,057,963
19	INCY	Incyte Corporation	2.94%	92,288
20	QGEN	Qiagen N.V.	2.86%	252,175
21	OMER	Omeros Corporation	2.78%	769,229
22	SRPT	Sarepta Therapeutics, Inc.	2.61%	537,572
23	PTCT	PTC Therapeutics, Inc.	2.54%	132,493
24	VCYT	Veracyte, Inc.	2.39%	202,699
25	EXEL	Exelixis, Inc.	2.38%	179,304

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of Aug 12, 2026